Personal tools

MCL coexpression mm9:314: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0.229925105835837,0.281033021353425,0.280440101118034,0.176350522035494,0.223110820673195,0.420828164225892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.510530790731187,0.452595073410909,0.197068726315728,0.269868638010351,0.360371362302498,0.745118692704118,0.631077476625533,0.6132313888735,0,0,0,0.19802531727213,0.367333024504598,0.207501896467584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107511441879825,0,0,0,0,0,0,0,0,0,0,0.330786781096625,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.927148048437346,0,0,0.550787138645144,0,0,0,0,0,0,0,0,0,0,0,0,0.354802331421785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.36580144956338,0.455020670504391,0,0,0.141951942539884,0.302854023491376,0.368150765366504,0.504400667364477,0.585141870708775,0.49707988402132,0.618976248966234,0.554662859595804,0.571650287722448,0.662311755447834,0.791502100226078,0.714494621038649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0998284739419172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.439156574576173,0,0,0,0,0,0,0,0,0,0,0.463794662544282,0,0,0.0849373898696927,0.151730312771305,0.258567039193022,0.223838914215041,0.198264997748062,0.311122885272949,1.15945182196718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0388749848471105,0.0523284672130554,0.0472245945615809,0,0.0476191773904887,0,0,0.0296538495026687,0,0.0709519923534245,0,0,0.0390607415003592,0.0352754493378881,0,0,0.0553034373508932,0,0,0.0408018333703219,0,0.0625582350728301,0,0,0.0506313079653279,0.0845301845292944,0,0,0
|coexpression_dpi_cluster_scores_median=0,0.229925105835837,0.281033021353425,0.280440101118034,0.176350522035494,0.223110820673195,0.420828164225892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.510530790731187,0.452595073410909,0.197068726315728,0.269868638010351,0.360371362302498,0.745118692704118,0.631077476625533,0.6132313888735,0,0,0,0.19802531727213,0.367333024504598,0.207501896467584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.107511441879825,0,0,0,0,0,0,0,0,0,0,0.330786781096625,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.927148048437346,0,0,0.550787138645144,0,0,0,0,0,0,0,0,0,0,0,0,0.354802331421785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.36580144956338,0.455020670504391,0,0,0.141951942539884,0.302854023491376,0.368150765366504,0.504400667364477,0.585141870708775,0.49707988402132,0.618976248966234,0.554662859595804,0.571650287722448,0.662311755447834,0.791502100226078,0.714494621038649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0998284739419172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.439156574576173,0,0,0,0,0,0,0,0,0,0,0.463794662544282,0,0,0.0849373898696927,0.151730312771305,0.258567039193022,0.223838914215041,0.198264997748062,0.311122885272949,1.15945182196718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0388749848471105,0.0523284672130554,0.0472245945615809,0,0.0476191773904887,0,0,0.0296538495026687,0,0.0709519923534245,0,0,0.0390607415003592,0.0352754493378881,0,0,0.0553034373508932,0,0,0.0408018333703219,0,0.0625582350728301,0,0,0.0506313079653279,0.0845301845292944,0,0,0
|gostat_on_MCL_coexpression=GO:0016757;transferase activity, transferring glycosyl groups;0.0011194633290528;67569,72077,14426!GO:0008375;acetylglucosaminyltransferase activity;0.0011194633290528;67569,72077!GO:0008194;UDP-glycosyltransferase activity;0.00565137585170196;67569,72077!GO:0005794;Golgi apparatus;0.00565137585170196;67569,72077,14426!GO:0016758;transferase activity, transferring hexosyl groups;0.00673005426702396;67569,72077!GO:0008109;N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity;0.00673005426702396;72077!GO:0003829;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;0.00673005426702396;72077!GO:0008454;alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity;0.00706578264803484;67569!GO:0042910;xenobiotic transporter activity;0.00706578264803484;18671!GO:0008559;xenobiotic-transporting ATPase activity;0.00706578264803484;18671!GO:0015239;multidrug transporter activity;0.0085636465461218;18671!GO:0046581;intercellular canaliculus;0.0137330008805963;18671!GO:0016021;integral to membrane;0.017698505694749;67569,72077,14426,213819,18671!GO:0031224;intrinsic to membrane;0.017698505694749;67569,72077,14426,213819,18671!GO:0015893;drug transport;0.0193728996622652;18671!GO:0006493;protein amino acid O-linked glycosylation;0.0193728996622652;72077!GO:0015238;drug transporter activity;0.0193728996622652;18671!GO:0044425;membrane part;0.0206057324480722;67569,72077,14426,213819,18671!GO:0016740;transferase activity;0.0328944759667272;67569,72077,14426!GO:0042493;response to drug;0.0352245386378794;18671!GO:0016020;membrane;0.0417803696323778;67569,72077,14426,213819,18671!
|gostat_on_MCL_coexpression=GO:0016757;transferase activity, transferring glycosyl groups;0.0011194633290528;67569,72077,14426!GO:0008375;acetylglucosaminyltransferase activity;0.0011194633290528;67569,72077!GO:0008194;UDP-glycosyltransferase activity;0.00565137585170196;67569,72077!GO:0005794;Golgi apparatus;0.00565137585170196;67569,72077,14426!GO:0016758;transferase activity, transferring hexosyl groups;0.00673005426702396;67569,72077!GO:0008109;N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity;0.00673005426702396;72077!GO:0003829;beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity;0.00673005426702396;72077!GO:0008454;alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity;0.00706578264803484;67569!GO:0042910;xenobiotic transporter activity;0.00706578264803484;18671!GO:0008559;xenobiotic-transporting ATPase activity;0.00706578264803484;18671!GO:0015239;multidrug transporter activity;0.0085636465461218;18671!GO:0046581;intercellular canaliculus;0.0137330008805963;18671!GO:0016021;integral to membrane;0.017698505694749;67569,72077,14426,213819,18671!GO:0031224;intrinsic to membrane;0.017698505694749;67569,72077,14426,213819,18671!GO:0015893;drug transport;0.0193728996622652;18671!GO:0006493;protein amino acid O-linked glycosylation;0.0193728996622652;72077!GO:0015238;drug transporter activity;0.0193728996622652;18671!GO:0044425;membrane part;0.0206057324480722;67569,72077,14426,213819,18671!GO:0016740;transferase activity;0.0328944759667272;67569,72077,14426!GO:0042493;response to drug;0.0352245386378794;18671!GO:0016020;membrane;0.0417803696323778;67569,72077,14426,213819,18671!
|ontology_enrichment_celltype=CL:0002563!1.04e-12!9;CL:0002251!1.04e-12!9;CL:0000239!5.16e-09!6;CL:0000677!5.16e-09!6;CL:0000212!5.16e-09!6;CL:0000584!5.16e-09!6;CL:0000075!1.32e-07!7;CL:0002076!7.04e-07!15
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0005409!4.16e-42!47;UBERON:0000160!2.62e-41!31;UBERON:0000344!4.42e-22!15;UBERON:0001242!4.86e-19!13;UBERON:0000060!4.86e-19!13;UBERON:0001262!4.86e-19!13;UBERON:0004786!4.86e-19!13;UBERON:0001007!6.55e-13!116;UBERON:0001555!6.55e-13!116;UBERON:0007026!6.55e-13!116;UBERON:0003350!1.04e-12!9;UBERON:0004808!1.04e-12!9;UBERON:0001277!1.04e-12!9;UBERON:0004119!1.63e-12!118;UBERON:0000925!1.63e-12!118;UBERON:0006595!1.63e-12!118;UBERON:0004923!3.06e-12!24;UBERON:0004921!2.65e-11!114;UBERON:0000485!4.75e-10!11;UBERON:0002108!5.90e-08!4
}}
}}

Revision as of 19:35, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:101837063..101837079,+p1@Mgat4c
Mm9::chr10:98570772..98570840,+p1@Galnt4
Mm9::chr11:58195782..58195801,+p@chr11:58195782..58195801
+
Mm9::chr11:58195812..58195827,+p@chr11:58195812..58195827
+
Mm9::chr11:58195835..58195850,+p@chr11:58195835..58195850
+
Mm9::chr11:58196339..58196348,+p@chr11:58196339..58196348
+
Mm9::chr11:58198109..58198122,+p@chr11:58198109..58198122
+
Mm9::chr11:58198170..58198190,+p@chr11:58198170..58198190
+
Mm9::chr11:58198242..58198248,+p@chr11:58198242..58198248
+
Mm9::chr11:58200272..58200306,-p@chr11:58200272..58200306
-
Mm9::chr11:58200324..58200338,-p@chr11:58200324..58200338
-
Mm9::chr11:58203653..58203660,-p@chr11:58203653..58203660
-
Mm9::chr11:58203666..58203680,-p@chr11:58203666..58203680
-
Mm9::chr11:58203760..58203791,-p@chr11:58203760..58203791
-
Mm9::chr11:58207426..58207436,+p@chr11:58207426..58207436
+
Mm9::chr13:101207449..101207462,-p@chr13:101207449..101207462
-
Mm9::chr5:113918124..113918145,+p@chr5:113918124..113918145
+
Mm9::chr5:8660059..8660099,+p1@Abcb1a
Mm9::chr6:4550658..4550676,+p5@Casd1
Mm9::chr7:26248671..26248685,+p@chr7:26248671..26248685
+
Mm9::chr7:26251376..26251402,-p@chr7:26251376..26251402
-
Mm9::chr7:31391945..31391961,-p@chr7:31391945..31391961
-
Mm9::chr7:52976606..52976614,+p2@Fam83e
Mm9::chr9:69885861..69885864,-p5@Gcnt3
Mm9::chrX:136059368..136059390,+p@chrX:136059368..136059390
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0016757transferase activity, transferring glycosyl groups0.0011194633290528
GO:0008375acetylglucosaminyltransferase activity0.0011194633290528
GO:0008194UDP-glycosyltransferase activity0.00565137585170196
GO:0005794Golgi apparatus0.00565137585170196
GO:0016758transferase activity, transferring hexosyl groups0.00673005426702396
GO:0008109N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity0.00673005426702396
GO:0003829beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity0.00673005426702396
GO:0008454alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity0.00706578264803484
GO:0042910xenobiotic transporter activity0.00706578264803484
GO:0008559xenobiotic-transporting ATPase activity0.00706578264803484
GO:0015239multidrug transporter activity0.0085636465461218
GO:0046581intercellular canaliculus0.0137330008805963
GO:0016021integral to membrane0.017698505694749
GO:0031224intrinsic to membrane0.017698505694749
GO:0015893drug transport0.0193728996622652
GO:0006493protein amino acid O-linked glycosylation0.0193728996622652
GO:0015238drug transporter activity0.0193728996622652
GO:0044425membrane part0.0206057324480722
GO:0016740transferase activity0.0328944759667272
GO:0042493response to drug0.0352245386378794
GO:0016020membrane0.0417803696323778



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>



TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}